However, although Adar-mediated RNA editing is linked to neurological alterations, the significance of this process in neurological disorders, such as FXS, and the global Fmrp-Adar mediated effect on the transcriptome, particularly neurological genes, are unclear. The gene discussed is FMR1; the disease is fragile X syndrome.